[57] TRISCEND Study.

[58] Kolte D, Elmariah S. Transcatheter Tricuspid Valve Therapy. Curr Treat Options Cardiovasc Med [Internet]. 2019 Jun 18 [cited 2020 Dec 11];21(6):26. Available from: http://link.springer.com/10.1007/ s11936-019-0730-7

[59] Laule M, Stangl V, Sanad W, Lembcke A, Baumann G, Stangl K. Percutaneous transfemoral management of severe secondary tricuspid regurgitation with edwards sapien XT bioprosthesis: First-in-man experience [Internet]. Vol. 61, Journal of the American College of Cardiology. J Am Coll Cardiol; 2013 [cited 2020 Dec 11]. p. 1929-31. Available from: https:// pubmed.ncbi.nlm.nih.gov/23500268/

[60] Dreger H, Mattig I, Hewing B, Knebel F, Lauten A, Lembcke A, et al. Treatment of Severe TRIcuspid regurgitation in patients with advanced heart failure with caval vein implantation of the edwards sapien XT valve (TRICAVAL): A randomised controlled trial. EuroIntervention [Internet]. 2020 Apr 1 [cited 2020 Dec 11];15(17):1506-13. Available from: https://pubmed.ncbi.nlm.nih. gov/31929100/

[61] Mattig I, Knebel F, Hewing B, Stangl V, Stangl K, Laule M, et al. Impact of inferior caval valve implantation on severity of tricuspid regurgitation and right heart function. Echocardiography [Internet]. 2020 Jul 14 [cited 2020 Dec 11];37(7):999-1007. Available from: https://onlinelibrary.wiley.com/doi/ abs/10.1111/echo.14760

### [62] Lauten A, Figulla HR,

Unbehaun A, Fam N, Schofer J, Doenst T, et al. Interventional Treatment of Severe Tricuspid Regurgitation. Circ Cardiovasc Interv [Internet]. 2018 Feb 1 [cited 2020

Dec 11];11(2). Available from: https:// pubmed.ncbi.nlm.nih.gov/29445001/

[63] Lauten A, Ferrari M, Hekmat K, Pfeifer R, Dannberg G, Ragoschke-Schumm A, et al. Heterotopic transcatheter tricuspid valve implantation: First-in-man application of a novel approach to tricuspid regurgitation. Eur Heart J [Internet]. 2011 May [cited 2020 Dec 11];32(10):1207-13. Available from: https://pubmed.ncbi.nlm.nih. gov/21300731/

[64] Toggweiler S, De Boeck B, Brinkert M, Buhmann R, Bossard M, Kobza R, et al. First-in-man implantation of the Tricento transcatheter heart valve for the treatment of severe tricuspid regurgitation. EuroIntervention [Internet]. 2018 Sep 1 [cited 2020 Dec 11];14(7):758-61. Available from: https://pubmed.ncbi.nlm.nih. gov/29969434/

[65] Montorfano M, Beneduce A, Ancona MB, Ancona F, Sgura F, Romano V, et al. Tricento Transcatheter Heart Valve for Severe Tricuspid Regurgitation: Procedural Planning and Technical Aspects. JACC Cardiovasc Interv [Internet]. 2019 Nov 11 [cited 2020 Dec 11];12(21):e189-91. Available from: https://linkinghub.elsevier.com/ retrieve/pii/S1936879819315213

[66] Werner P, Russo M, Scherzer S, Aref T, Coti I, Mascherbauer J, et al. Transcatheter Caval Valve Implantation of the Tricento Valve for Tricuspid Regurgitation Using Advanced Intraprocedural Imaging. JACC Case Reports [Internet]. 2019 Dec [cited 2020 Dec 11];1(5):720-4. Available from: https://linkinghub.elsevier.com/ retrieve/pii/S2666084919304735

[67] Orban M, Rommel KP, Ho EC, Unterhuber M, Pozzoli A, Connelly KA, et al. Transcatheter Edge-to-Edge Tricuspid Repair for Severe Tricuspid Regurgitation Reduces Hospitalizations

for Heart Failure. JACC Hear Fail. 2020 Apr 1;8(4):265-76.

[68] Taramasso M, Alessandrini H, Latib A, Asami M, Attinger-Toller A, Biasco L, et al. Outcomes After Current Transcatheter Tricuspid Valve Intervention: Mid-Term Results From the International TriValve Registry. JACC Cardiovasc Interv [Internet]. 2019 Jan 28 [cited 2020 Dec 11];12(2):155-65. Available from: https://pubmed.ncbi. nlm.nih.gov/30594510/

[69] Taramasso M, Benfari G, van der Bijl P, Alessandrini H, Attinger-Toller A, Biasco L, et al. Transcatheter Versus Medical Treatment of Patients With Symptomatic Severe Tricuspid Regurgitation. J Am Coll Cardiol [Internet]. 2019 Dec 17 [cited 2020 Dec 11];74(24):2998-3008. Available from: https://pubmed.ncbi.nlm.nih. gov/31568868/

[70] Lurz P, Orban M, Besler C, Braun D, Schlotter F, Noack T, et al. Clinical characteristics, diagnosis, and risk stratification of pulmonary hypertension in severe tricuspid regurgitation and implications for transcatheter tricuspid valve repair. Eur Heart J [Internet]. 2020 Aug 1 [cited 2020 Dec 11];41(29):2785-95. Available from: https://pubmed.ncbi.nlm.nih. gov/32176280/

[71] Stocker TJ, Hertell H, Orban M, Braun D, Rommel K-P, Ruf T, et al. Cardiopulmonary Hemodynamic Profile Predicts Mortality After Transcatheter Tricuspid Valve Repair in Chronic Heart Failure. JACC Cardiovasc Interv [Internet]. 2020 Dec [cited 2020 Dec 11]; Available from: https:// linkinghub.elsevier.com/retrieve/pii/ S1936879820319713

[72] D'Alto M, Naeije R. Transcatheter tricuspid valve repair in patients with pulmonary hypertension [Internet]. Vol. 41, European Heart Journal. Oxford University Press; 2020 [cited 2020

Dec 11]. p. 2811-2. Available from: https://academic.oup.com/eurheartj/ article/41/29/2811/5865473

[73] Besler C, Unterhuber M, Rommel KP, Unger E, Hartung P, von Roeder M, et al. Nutritional status in tricuspid regurgitation: implications of transcatheter repair. Eur J Heart Fail [Internet]. 2020 Oct 26 [cited 2020 Dec 11];22(10):1826-36. Available from: https://onlinelibrary.wiley.com/ doi/10.1002/ejhf.1752
